Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Gattenlohner, S; Etschmann, B; Riedmiller, H; Muller-Hermelink, HK.
Lack of KRAS and BRAF mutation in renal cell carcinoma.
Eur Urol. 2009; 55(6):1490-1491
Doi: 10.1016/j.eururo.2009.02.024
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Gattenlöhner Stefan
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Find related publications in this database (using NLM MeSH Indexing)
-
Antibodies, Monoclonal - therapeutic use
-
Biopsy, Needle -
-
Carcinoma, Renal Cell - drug therapy Carcinoma, Renal Cell - genetics Carcinoma, Renal Cell - pathology
-
Cohort Studies -
-
DNA Mutational Analysis -
-
Female -
-
Follow-Up Studies -
-
Gene Expression Regulation, Neoplastic -
-
Genes, ras - drug effects Genes, ras - genetics
-
Humans -
-
Immunohistochemistry -
-
Kidney Neoplasms - drug therapy Kidney Neoplasms - genetics Kidney Neoplasms - pathology
-
Male -
-
Mutation -
-
Polymerase Chain Reaction -
-
Proto-Oncogene Proteins B-raf - drug effects Proto-Oncogene Proteins B-raf - genetics
-
Receptor, Epidermal Growth Factor - therapeutic use
-
Risk Assessment -
-
Sensitivity and Specificity -